Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

MYCITRACIN

BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Standard Dose
500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MYCITRACIN is listed in Drugs@FDA under application 061048 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview MYCITRACIN is listed in Drugs@FDA under application 061048 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 500 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.